Tianli International Holdings Limited (01773) received an increase of 1.7 million shares by executive director Luo Shi.
Tian Li International Holdings Limited (01773) announced that the Board of Directors received notification from the company's executive director, chairman, and CEO, Mr. Luo Shi, that on January 13, 2026, Mr. Luo purchased a total of 1.7 million shares of the company's common stock in the open market, representing approximately 0.08% of the total number of issued shares of the company, at an average price of about HK$2.85 per share. Following the purchase, Mr. Luo directly and indirectly holds a total of 918 million shares of the company, representing approximately 43.86% of the total number of issued shares of the company as of the date of this announcement. Mr. Luo has also been granted 30 million share options under the share option scheme, giving him the right to subscribe for 30 million shares, but it is unlikely that these options will be exercised as of the date of this announcement.
TIANLI INT HLDG (01773) announced that the board of directors received notification from the company's executive director, chairman and CEO, Mr. Luo Shi, that on January 13, 2026, Mr. Luo purchased a total of 1.7 million shares of the company's common stock on the open market, representing approximately 0.08% of the total number of issued shares of the company, at an average price of approximately HK$2.85 per share. Following the purchase, Mr. Luo directly and indirectly holds a total of 918 million shares of the company, representing approximately 43.86% of the total number of issued shares on the date of this announcement. Mr. Luo has also been granted 30 million share options under a share option plan, giving him the right to subscribe for 30 million shares, which are currently unexercised as of the date of this announcement.
Related Articles

KNOWLEDGE ATLAS (02513) collaborates with Huawei to open source the first domestic chip training multi-modal SOTA model.

Apple Inc. (AAPL.US) launches "Creator Studio" subscription package: bundling creative apps such as Final Cut Pro for a monthly fee of $12.99.

LAEKNA-B (02105): The US Food and Drug Administration has accepted the clinical trial application for the new drug LAE118.
KNOWLEDGE ATLAS (02513) collaborates with Huawei to open source the first domestic chip training multi-modal SOTA model.

Apple Inc. (AAPL.US) launches "Creator Studio" subscription package: bundling creative apps such as Final Cut Pro for a monthly fee of $12.99.

LAEKNA-B (02105): The US Food and Drug Administration has accepted the clinical trial application for the new drug LAE118.

RECOMMEND

Institutions Bullish On Hong Kong Stocks As Spring Rally Builds; Domestic And Foreign Capital Increase ETF Allocations
13/01/2026

The Sword Over Hong Kong Stocks: IPO Peaks And Unlocking Waves
13/01/2026

Learning From History: The AI Investment Wave Likely To End This Year, But The Fed May Shield U.S. Stocks
13/01/2026


